Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.
about
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Herceptin® (trastuzumab) in HE ...... ulative network meta-analysis.
@en
type
label
Herceptin® (trastuzumab) in HE ...... ulative network meta-analysis.
@en
prefLabel
Herceptin® (trastuzumab) in HE ...... ulative network meta-analysis.
@en
P2093
P2860
P50
P1433
P1476
Herceptin® (trastuzumab) in HE ...... mulative network meta-analysis
@en
P2093
Chris Cameron
Christine Brezden-Masley
Mariya Yurchenko
Megan E Coombes
Quinlan Wylie
P2860
P2888
P356
10.1186/S13643-017-0588-2
P577
2017-10-10T00:00:00Z
P6179
1092156253